Abiopharma

Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

Abivax Presents Third Quarter 2025 Financial Results

Indivior Notification

IO Biotech, Inc. - IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications

OmniAb - Launch of OmniUltra Expands OmniAb’sReach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies

IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications

Madrigal Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

AEON Biopharma Announces Execution of Exchange Agreement with Daewoong

Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies